Kirkov Kirko 4
4 · ELITE PHARMACEUTICALS INC /NV/ · Filed Nov 14, 2022
Insider Transaction Report
Form 4
Kirkov Kirko
Chief Commercial Officer
Transactions
- Award
Options
2022-09-06$0.04/sh+3,000,000$105,000→ 3,000,000 totalExercise: $0.04From: 2023-09-06Exp: 2032-09-06→ Common Stock (3,000,000 underlying)
Footnotes (2)
- [F1]The Board of Directors approved and awarded options on November 10, 2022, as part of Mr. Kirkov's employment agreement dated September 6, 2022.
- [F2]The options will vest over a three-year period, commencing one year from the date of issuance. The first third will vest on September 6, 2023.